Proteomics - Research and Markets - RSS Feed

Proteomics - International Market Trends

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:51 GMT

The shift from genomics to proteomics paves way for technological advancements assisting drug discovery researchers by offering added sensitivity, increased throughput and increased resolution from traditional protein research tools A major market growth driver is the explosion in scientific...

Innovations in Protein Kinase Therapies: Company Pipelines, Therapeutic Applications and Market Forecasts

press@researchandmarkets.com — Fri, 14 Aug 2009 10:23:09 GMT

During the last decade, approvals for several first-in-class kinase inhibitors have resulted in a wider recognition of kinases as an important class of drug targets In the cancer market, there are now seven launched agents targeting EGFR family kinases, three agents targeting ABL family kinases and...

Automation in Proteomics and Genomics: An Engineering Case-Based Approach

press@researchandmarkets.com — Wed, 13 May 2009 15:08:03 GMT

In the last decade DNA sequencing costs have decreased over a magnitude, largely because of increasing throughput by incremental advances in tools, technologies and process improvements Further cost reductions in this and in related proteomics technologies are expected as a result of the development...

Prion Journal

press@researchandmarkets.com — Thu, 23 Apr 2009 10:28:54 GMT

Prion is the first international peer-reviewed journal to focus exclusively on protein folding and misfolding, protein assembly disorders, protein-based and structural inheritance This new journal is important for several reasons Considerable experimental evidence challenges the traditional concept...

Know the Other "Omics": Exploring Drug and Diagnostics Development Through Proteomics

press@researchandmarkets.com — Wed, 08 Apr 2009 11:08:59 GMT

Genomics has paved the way for its cousin, proteomics, to secure its share of the “omics” hype Researchers look to proteomics to deliver on the promise to assess the viability of drug targets for monitoring disease progression, optimizing disease management, and diagnosing diseases with more...

Plant Proteomics

press@researchandmarkets.com — Fri, 30 Jan 2009 16:00:52 GMT

Confidently face the challenges of proteomics research specific to plant science with the information in Plant Proteomics, which will introduce you to the techniques and methodologies required for the study of representative plant species Read about proteomics studies in Arabidopsis, rice, and...

Competitor Analysis: CD20 Antibodies

press@researchandmarkets.com — Wed, 28 Jan 2009 15:07:43 GMT

The present Competitive Intelligence Report about anti-CD20 antibodies used to treat B-cell mediated malignancies and rheumatoid arthritis provides a competitor evaluation in the field of R&D projects with anti-CD20 antibodies as of January 2009 The chimeric anti-CD20 antibody rituximab (Rituxan &...

Protein Research: Strategies for Marketing to Chemists and Biologists

press@researchandmarkets.com — Fri, 23 Jan 2009 10:04:52 GMT

The study of protein research is growing in complexity, leading to increased demand on the instrumentation used to conduct the research, and scientists are being tasked to meet these growing demands while dealing with greater budget constraints With that, both biologists and chemists are looking...

U.S. Protein Ingredients Markets

press@researchandmarkets.com — Tue, 06 Jan 2009 16:20:46 GMT

This research service tracks the key trends in the U S protein ingredients markets, while also quantifying the markets in terms of revenue and unit shipment Key companies and trends are discussed It provides unit shipment, price and revenue forecasts at a total market and segment level, from 2008 to...

Mass Spectrometry Analysis for Protein-Protein Interactions and Dynamics

press@researchandmarkets.com — Mon, 26 May 2008 13:46:00 GMT

- Presents a wide variety of mass spectrometry methods used to explore structural mechanisms, protein dynamics and interactions between proteins - Preliminary chapters cover mass spectrometry methods for examining proteins and are then followed by chapters devoted to presenting very practical,...

U.S. CoenzymeQ10 Markets

press@researchandmarkets.com — Thu, 10 Apr 2008 13:40:08 GMT

This Frost & Sullivan research service titled U S CoenzymeQ10 Markets provides revenue and unit shipment forecasts, company profiles, and strategic analysis In this research, Frost & Sullivan's expert analysts thoroughly examine the U S coenzymeQ10 markets in dietary supplement and food and beverage...

Human Blood Plasma Proteins: Structure and Function

press@researchandmarkets.com — Mon, 10 Mar 2008 16:47:41 GMT

Human Blood Plasma Proteins gives an overview of the proteins found in human blood plasma, with special emphasis on their structure and function and relationship to pathological states and disease Topics covered include: -introduction to blood components and blood plasma proteins -blood plasma...

Proteomics Sample Preparation

press@researchandmarkets.com — Wed, 05 Mar 2008 14:48:43 GMT

This long-awaited first guide to sample preparation for proteomics studies overcomes a major bottleneck in this fast growing technique within the molecular life sciences By addressing the topic from three different angles -- sample, method and aim of the study -- this practical reference has...

Chemical and Functional Genomic Approaches to Stem Cell Biology and Regenerative Medicine

press@researchandmarkets.com — Wed, 13 Feb 2008 16:25:10 GMT

Functional genomic approaches including genome-wide expression analysis, large-scale gain and loss of function genetic studies with cDNA and RNAi libraries, chemical genomics, high throughput cell-based screens, and proteomics are just emerging to rapidly fill the gap in our knowledge of stem cell...

Protein Degradation Series, 4 Volume Set

press@researchandmarkets.com — Mon, 11 Feb 2008 16:07:43 GMT

Nobel prize content by Nobel prize winners: The essential role of protein degradation as a regulatory switch in cell physiology has been honored by the 2004 Nobel prize in Chemistry to Aaron Ciechanover, editor of the series, and Avram Hershko, the author of the opening chapter of volume 1 -Broad...

Transforming Drug Discovery through Genomics and Proteomics

press@researchandmarkets.com — Mon, 11 Feb 2008 14:17:29 GMT

In medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are discovered and/or designed In the past most drugs have been discovered either by identifying the active ingredient from traditional remedies or by serendipitous discovery A new approach has been to...

Peptidomics: Methods and Applications

press@researchandmarkets.com — Wed, 23 Jan 2008 16:40:25 GMT

This book describes the methods of peptidomics for the study of proteins, how it works, and applications in areas from drug discovery to toxicity biomarker analysis The book provides information that is both sufficiently detailed to be a step-by-step guide for beginning researchers, while also being...

European Protein Purification Markets

press@researchandmarkets.com — Mon, 03 Dec 2007 16:33:50 GMT

Increased Research in the Pharmaceutical and Biotechnological Arenas Propels the Protein Purification Market The growing need to identify new ligands and rapid purification kits is driving research and growth in the European protein purification markets The increasing requirement for the production...

Proteomic Biology Using LC/MS: Large Scale Analysis of Cellular Dynamics and Function

press@researchandmarkets.com — Fri, 23 Nov 2007 14:50:52 GMT

This is one of the first books to focus on the dynamic aspect of proteomes The book introduces proteomics to the newcomer, reviews the theoretical aspects of proteomics and its state-of-the art technologies, along with a number of biological applications using "classical" proteomic technology The...

Computational Methods for Mass Spectrometry Proteomics

press@researchandmarkets.com — Wed, 21 Nov 2007 16:23:14 GMT

This book uniquely provides basic knowledge and principles of proteomic bioinformatics and mass spectrometry Computational Methods for Mass Spectrometry Proteomics covers the bioinformatics problems and how they are solved, which types of programs are used and the different principles / algorithms...

Proteomics in Practice: A Guide to Successful Experimental Design, Second, Completely Revised Edition

press@researchandmarkets.com — Wed, 14 Nov 2007 15:04:21 GMT

From a practical application perspective, the authors present the relevant techniques and explain the route to successful experimental design and optimal method selection Coverage includes electrophoretic techniques such as isoelectric focussing, SDS page, 2-D page, DIGE, liquid-chromatography...

Introduction to Soft Matter: Synthetic and Biological Self-Assembling Materials, Revised Edition

press@researchandmarkets.com — Tue, 09 Oct 2007 11:45:39 GMT

This book provides an introduction to this exciting and relatively new subject with chapters covering natural and synthetic polymers, colloids, surfactants and liquid crystals highlighting the many and varied applications of these materials Written by an expert in the field, this book will be an...

Mass Spectrometry of Protein Interactions

press@researchandmarkets.com — Mon, 08 Oct 2007 14:55:06 GMT

The authoritative guide to analyzing protein interactions by mass spectrometry Mass spectrometry (MS) is playing an increasingly important role in the study of protein interactions Mass Spectrometry of Protein Interactionspresents timely and definitive discussions of the diverse range of approaches...

G-Protein Coupled Receptors (GPCRs) 2007 Market Report

press@researchandmarkets.com — Mon, 08 Oct 2007 11:50:47 GMT

This industry report focuses upon the technology and market trends in the GPCRs target space Given the central and essential role GPCRs occupy as a drug target class, it is important for industry participants to map the landscape in terms of both biological/technical aspects of the target class as...

Biomed Outsourcing Report: Biopathways, New Targets, New Opportunities in Discovery Research

press@researchandmarkets.com — Thu, 07 Jun 2007 13:53:34 GMT

A new biological paradigm, Systems Biology, has emerged with the completion of the Human Genome Project Systems biology aims to develop a systems-level understanding of biological processes System biology knowledge is complex and derives from a variety of scientific and technical disciplines...

Glial Neurobiology

press@researchandmarkets.com — Wed, 16 May 2007 11:42:37 GMT

Glial Neurobiology is the first comprehensive, accessible textbook of glial neurobiology Authored by leading experts in the field, it provides a concise, thorough and up-do-date overview of glial cells function, the role of glial cells in various neural processes and their involvement in nervous...

Microarray Product Revenue: Arrays, Reagents and Instruments, 2005 and 2010

press@researchandmarkets.com — Fri, 02 Feb 2007 15:11:59 GMT

This Database Table is a one-page table of hard-to-find numerical information. Database Tables are proprietary data sources covering specific information for the diagnostic, medical device, biotechnology, healthcare and IT sectors. Over 600 database tables are now available from Research and Markets.

A Note on Database Tables at Research and Markets: Please note that these database tables are very focused one or two page tables/charts. They are great as a quick snapshot of a given market, or to incorporate into your own presentations/forecasts. But they not give the detailed analysis and the comprehensive information found in the full industry/market reports. If you do require more detailed market research please visit the following categories at Research and Markets: Pharmaceuticals, Healthcare and Medical Devices, and Biotechnology.

World Proteomics Liquid Chromatography Markets

press@researchandmarkets.com — Tue, 09 Jan 2007 11:35:07 GMT

Limited Volume of Protein Samples Restricts Number of LC Experiments

In many proteomics research programs, protein sample availability restricts liquid chromatography (LC) experiments. Researchers are often unable to conduct the entire range of experiments desired since only small amounts of valuable protein samples are available. Answering numerous questions with limited sample is difficult. Moreover, with researchers often having to prioritize experiments, researchers are unable to conduct thorough studies.

This Frost & Sullivan strategic analysis service offers gainful insights into future trends in the protein LC market. These can help investors study growth patterns and obtain maximum return on investment.

Need to Extract Greater Amounts of Proteomic Information Drives LC Uptake

Interest and level of activity in the field of proteomics remains high because crucial information is yet to be gathered from proteins, says the analyst. Researchers are still on the lookout for the product that will enable them to draw information accurately and efficiently. As the study of proteins gains importance in other industries and research markets, the demand for protein LC technologies is expected to continue growing.

High-level Capabilities of LC Spurs Integrated Solutions

The superior capabilities of LC to analyze complex samples when coupled with mass spectrometry (MS) are propelling deployment of integrated LC systems. Manufacturers, recognizing the needs of researchers working on advanced analysis, are striving to offer technologies such as fully integrated LC-MS systems. These total solution systems are likely to provide researchers with sophisticated analysis tools offering higher ease of use. Sustained innovation is anticipated to further increase LC adoption.

World Proteome Informatics Markets

press@researchandmarkets.com — Tue, 09 Jan 2007 11:35:07 GMT

Compatibility and Integration Issues Create Technical Challenges for Proteome Informatics Market

Technical challenges relating to the integration of equipment and data weaken the appeal of proteomics informatics. As the market develops and new technologies are launched, vendors attempt to address these challenges. The issue, however, creates an ongoing struggle in the broader life science research setting and has to be resolved in order to provide maximum possible value and eliminate incompatibilities. Given the growing number of techniques developed in proteomics, the need to corroborate information is vital. However, the complexity of enabling the many possible combinations creates its own set of limits. Vendors must address the changing environments of alliances, public initiatives and standards, as well as the technological trends, and then decide appropriate strategies.

This research examines the world proteomics informatics markets. It offers revenue forecasts by broad application area segments - expression, structural, and interaction proteomics - and covers key drivers and restraints influencing market growth. It also provides strategic recommendations to overcome market challenges. This research service includes segments focusing on standardization and the innovative integration of interfaces.

Continuous Evolution and Increasing Complexity of Proteomics Drives Growth in Software

The traditional proteomics approaches are constantly being complemented by new technologies or variations, says the analyst of this study. While these changes are gradual in some areas, they are dramatic in other segments of the market, creating an urgent need for software to integrate information and processes in a manageable, efficient, and flexible manner.

Improvements in software include visualization and data mining, automation of data acquisition and analysis, as well as knowledge-based approaches to crystallization. Hi-tech advances in recent years have been so rapid

World Functional Proteomics Markets

press@researchandmarkets.com — Tue, 09 Jan 2007 11:35:07 GMT

Complicated Protein Network of Organisms Slows Development of Interaction Map

Researchers across the world are showing greater interest in developing a vast knowledge-base of functional proteomics, similar to what they have accomplished for genomics. However, complex protein network in biological systems are posing significant challenges in their study of protein function and subsequent development of protein interaction map. They are also facing a daunting task of proving that 'in vitro' production of proteins during post-translational modifications is an accurate representation of 'in vivo' production of proteins. This is despite the fact that many expression systems have produced modification patterns very similar to that of humans.

This research on the world functional proteomics market probes the various steps involved in protein function determination apart from providing a thorough examination of three key market segments: protein-protein interactions, post-translational modifications, and informatics tools used for protein function analysis.

Desire to Understand Cell Signaling Pathways Drives Interest in Protein Function

Disrupted protein activities are the likely cause of many diseases that can be controlled by protein modifications. However, it is impossible to modify protein activity to the point of canceling the signaling mechanism completely. The need to accurately understand these situations is driving greater interest in protein functional determination studies.

A flurry of development is expected in the near future, as prospects of understanding cell pathways and the manner in which cells communicate are increasing. Functional proteomics has enabled researchers and companies to gain a novel and deeper understanding of cell systems and pathway properties, says the analyst. This is likely to provide an insight into the disease mechanisms, leading to new therapeutic regimens for combating diseases. In addition, a thorough knowledge of pathways i

Proteomics Market Profiles

press@researchandmarkets.com — Tue, 09 Jan 2007 11:35:07 GMT

Drive for Efficient Drug Discovery Spurs Proteomics Markets

As pharmaceutical firms strive to optimize drug development, proteomics, the
analysis of proteins expressed in human cells, will play an increasingly
important role in their efforts. By charting the distribution of proteins,
identifying and characterizing proteins of interest, and elucidating the
function of proteins in biochemical pathways, proteomics will boost the

number of potential drug targets around which lead compounds can be
screened and designed. Applying proteomic analysis to toxicology trials will
also allow drug companies to evaluate compounds faster, thereby minimizing
research and development expenditures.

This Frost & Sullivan research profiles leading participants in proteomic
markets. It provides a corporate overview for each firm, evaluates core
proteomics technologies and product offerings, and provides expert revenue
forecasts. With such a privileged view of the competitive field, users of this
study will gain important insights into the proteomics marketplace.

Genomic Information Gap Refocuses Research on Proteins

Sequencing of the human genome revealed that there are far fewer genes
than scientists originally believed, says the analyst responsible for this study.
Furthermore, genomic data has provided little information on
post-translational modifications, the role of proteins in biochemical pathways,
or disease states. Consequently, there has been a significant shift from

research on genomes to the large-scale high-throughput analysis of proteomes,
states the author.

To generate the necessary throughput and achieve the required reproducibility,

market participants are moving toward integrated and automated proteomics
solutions. By tracking technology trends and assessing their impact on market
success, this study will enable your firm to better anticipate the future
direction of the industry.

Tool Providers Lead Revenue Gains

Proteomics companies can be divided into

Opportunities for Proteomics Technology Markets in Europe

press@researchandmarkets.com — Tue, 09 Jan 2007 11:35:07 GMT

Low Return on Investment that can Dissuade Potential Entrants in Proteomics Technology Markets Offset by Increasing Public Funding
Proteomic research requires huge capital investments and currently, yields poor revenues. Companies, therefore, infer that the market lifecycle is at a stage where they need to wait before witnessing profits. In addition, pharmaceutical companies are doubtful about adopting this new technology in their drug development pipeline as they are wary of premium pricing. However, public funding institutions are giving importance to this growing biological discipline next to comparative genomics. The proteomics market is considered an emerging area with immense potential. In fact, Governments and federal ministries in the three major countries, namely the United Kingdom, France and Germany, are allocating thematic priorities to nurture the growth of this market. This is likely to result in greater industrialization of this field, which in turn, will boost the confidence of companies to invest in this fast-paced and dynamic arena.

This

Additional Information

Technological Innovation to Propel the Proteomics Market
"The increasing relevance of protein-protein interactions and protein analytics in drug discovery as well as clinical diagnostics has highlighted the importance of proteome research," says the analyst of this study. "The technological shift towards proteome research following the completion of the Human Genome Project combined with technological innovations of instruments is likely to increase the significance of proteome research."
Technological advancements in protein separation technologies and two-dimensional gel electrophoresis are likely to usher in a ubiquitous approach to assess differential protein expressions. Maximum utility of expression proteomics tools in the target discovery phase of drug development is likely to trigger reliable separation and identification of low abundant proteins with poor

U.S. Proteomics Sample Preparation Markets

press@researchandmarkets.com — Tue, 09 Jan 2007 11:35:07 GMT

Complexity in Proteomics Chemistry Challenges the Development of Standard Sample Solutions
Need for consistency and standardization in proteomics has limited the success of solutions for proteomics sample preparation. Without effective standards, researchers use divergent methods to investigate their proteins, making it unrealistic to compare their data sets. Until standards emerge, the continual generation of randomized data sets is likely to contribute to the increasing complexity of proteomics research as well as sample preparation. Each new application creates yet another small niche with few participants within the proteomics community. This decreases opportunities for suppliers of proteomics sample preparation solutions by limiting the potential sales of a certain product.
This Frost & Sullivan research analyzes the global market for proteomics sample preparation and transition of molecular biologists from genomics to proteomics. It provides detailed insights into recent developments and trends. The study also includes market forecasts along with competitive and opportunity analysis.
Increasing Participation of Molecular Biologists in Proteomic Research Increases Demand for Sample Preparation Kits
Since the study of proteomics offers wider solutions and comprehensive results, molecular biologists - alongside genomic study - are exploring proteomics. These researchers are used to prepackaged comprehensive kits for sample preparation, which is a relatively streamlined process for nuclei acid sample preparation in genomics. Therefore, as molecular biologists shift from genomic research to proteomics, similar kits that offer improved convenience and optimized protocols are expected to be required in the latter.
As long as proteomics research continues to draw molecular biologists and researchers from other eclectic backgrounds, the demand for comprehensive sample preparation kits is also likely to continue rising, notes the analyst of this research s

World Proteomics Sample Preparation Market

press@researchandmarkets.com — Tue, 09 Jan 2007 11:35:07 GMT

Focus on Proteomics Spur Sample Preparation Techniques
Emphasis on protein drug targets and biomarkers is stimulating interest in proteomics and triggering significant technological advances in the field. The number of assays being performed and samples analyzed are increasing, and the demand for sample preparation products is expected to grow notably. Applications designed to provide proteomics and drug-discovery researchers with higher throughput, added sensitivity, and improved resolutions are urgently required. Manufacturers offering solutions that simplify sample preparation procedures can gain a considerable share of the rapidly growing proteomics market.
This Frost & Sullivan research analyzes the global market for proteomics sample preparation, segmented into two categories: prior to running a 2D gel electrophoresis, and prior to analysis on a mass spectrophotometer. It provides detailed insights into recent developments and trends. The study also includes market forecasts along with competitive and opportunity analysis.

Technology Advances Will Fuel Increased Sample Throughput
Automation and improved techniques boost efficiency of sample preparation. The growing number of high throughput facilities is aiding researchers and feeding their interest in sample preparation solutions. Advances in microfluidic and microarray technologies have amplified the need for higher throughput, miniaturized, and automated sample preparation processes, says the analyst of this study.
The constantly evolving and dynamic nature of proteomics tool sets means a consistent need for focus on quality, service, and conviction to build the brand with life science researchers as they entrust manufacturers with funding dollars. Researchers engaged in drug discovery are sluggish adopters in terms of novel technologies, and a strong trusted brand can aid the adoption of fresh research solutions, says the analyst.

Development of Standard Sample Preparation Solution Challenged by Divergen

World Proteomics Automation Markets

press@researchandmarkets.com — Tue, 09 Jan 2007 11:17:52 GMT

Standardization of Interfaces to Facilitate Automation of Proteomics

The appeal of automating proteomics methods is being somewhat diminished by technical challenges relating to integration of equipment and data. The need to combine methods for varied and complex samples creates the problem of interfacing processes that are not easily merged. Standardization of interfaces is expected to eliminate such incompatibilities and do away with the dilemma of launching a technology at the expense of an existing one. Vendors are beginning to address these challenges as the market develops and the next generation of products is introduced.

This Frost & Sullivan research examines the World Proteomics Automation Markets. It offers revenue forecasts by market segments and covers key drivers and restraints affecting market growth. It also provides strategic recommendations to overcome market challenges. This report focuses on modular automation products and the integrated systems bundled from these devices.

Proteomics Methods' Proven Success Boosts Adoption

The typical proteomics approach of 2-D gel electrophoresis (2DGE) and mass spectrometry (MS) is being acknowledged as the method of choice for separating proteins and identifying subsets, states the analyst. However, advances in other technologies have led the market to believe that complementary technologies will be used for alternative separation steps such as multi-dimensional liquid chromatography and protein chips/arrays. Reagents for differential isotope labeling have also been formulated and are expected to develop.

Despite the optimism triggered by these advances and complaints about 2DGE's time and procedural constrains, it is still the most common method for resolving thousands of proteins before the subsequent analysis. End users are more likely to automate their existing 2DGE-MS process than invest in new technologies since the others have not been as successful on a wide range of samples. Apart from separat

World Structural Proteomics Markets

press@researchandmarkets.com — Tue, 09 Jan 2007 11:17:52 GMT

Desire for High Throughput Protein Crystallography Ignites Demand for Automated Crystallization

The need to understand exactly how small molecules bind to their protein target is driving the demand for protein crystallography in drug discovery. A higher throughput protein crystallography process requires protein crystallization to also become high throughput and this is best achieved through automated crystallization. A number of large proteomic initiatives are being launched, increasing market opportunities for automated crystallization.

This Frost & Sullivan research analyzes the global market for structural proteomics. It provides an analysis of market drivers, restraints, and forecasts, identifying areas of growth. The study covers liquid handlers used for protein purification; automated protein crystallization instruments; nuclear magnetic resonance (NMR) spectrometers, and X-ray systems used for protein studies.

Drug Discovery Initiatives Drive Technological Advancements in Structural Proteomics

Pharmaceutical companies agree that structure discovery helps lead optimization, says the author of the study. With rapid technology advances, structure-based design is set to become a preferred method for discovering new drugs.

As an increasing number of companies discover the importance and significance of protein structure studies for drug discovery, more efforts are being made toward improving structural determination technologies. Market consolidation and industrialization along with the introduction of powerful integrated systems is changing research approaches. Besides automation, miniaturization of protein crystals and processes including purification is another big trend.

Lack of Experienced Researchers Increases Need for Automated Crystallization

Protein crystallization is a process that requires training, skill, and time. The number of trained researchers and people willing to commit to such a process is decreasing. The surge in automation has add

World Proteomics Markets

press@researchandmarkets.com — Tue, 09 Jan 2007 11:17:51 GMT

Post-Genomics Focus Leads to Expanding Scope

and Explosive Growth Identification

Now that the human genome has been mapped, many people are wondering about the next step. The answer is proteomics, the study of protein output at the cellular level. This billion-dollar industry is expected to grow tremendously over the next several years. Since the proteomics industry is still in an embryonic-emergent stage, there are no clear dominant suppliers of instrument and supplies, services, or bioinformatics, which creates many opportunities for innovation from both the technological and business perspectives.

This Frost & Sullivan study presents a broad overview of the world proteomics markets. It is one of the first reports written from a business perspective, as opposed to other market research that focuses on the technology
of the industry. This report is an excellent resource for companies that want to take advantage of key market opportunities.

Bioinformatics Segment Will Outpace Others

Bioinformatics will grow faster than the instruments, supplies, and services segments because proteomics will generate a tremendous amount of data that needs to be analyzed.

The bioinformatics component of the proteomics market will grow very quickly in value, states the author of this report. Companies that can best mine their data and convert it into actionable knowledge will win. Databases will become increasingly valuable intellectual property.

Users of this report can benefit from the most up-to-date market intelligence available, including extensive tables of suppliers and products, deals, and funding
activities, which can put them on the inside track and help them pull ahead of the competition.

Technology Spurs New Opportunities

New technologies such as solution-phase, capillary electrophoresis, and microfluidic separations are slowly replacing 2-D gels. The discovery of even newer analytical technologies will challenge the market by creating new sub-segments, as

Genomics and Proteomics Markets in Australia

press@researchandmarkets.com — Tue, 09 Jan 2007 11:17:50 GMT

Increasing Research Drives Genomics and Proteomics Market in Australia

Extensive research in genomics and proteomics is promising cures for previously untreatable diseases. With the Government assisting by providing additional tax concessions, the spending on research and development (R&D) is likely to increase by 66.0 percent in 2005. As a result, more than 300 biotechnology companies focusing on genomics and proteomics applications have set up operations in Australia to take advantage of this favorable environment. Drug discovery companies are also likely to have ample opportunities to slightly modify the lead compound in order to screen and exclude patients of a certain genotype who are more prone to developing certain side effects from clinical trials.

This Frost & Sullivan research service provides an overview of and an outlook for the Australian genomics and proteomics market. It segments the market into structural and functional genomics and structural and functional proteomics. It provides detailed revenue forecasts and market share analyses and is essential for both large and small market participants seeking to position themselves to earn maximum return on investments.

Research Companies Must Team-up with Venture Capitalists for Funds

Compared to Western countries, most of the Australian biotech companies are start-up undertakings that are in need of capital to support their research. However, venture capitalists (VCs) are hesitant to provide funds since these companies have few products in the final stages of drug discovery and have to wait for around ten years for their products to complete clinical trials before releasing them into the market.

The long gestation period and the low market awareness on the potential of biotech products have led to insufficient funding of the biotech ventures in Australia as investors perceive them as being too risky, points out the analyst of the research service. The Australian government and the top research compan

U.S. Proteomics Sample Preparation Market, 2005-2012

press@researchandmarkets.com — Tue, 19 Dec 2006 12:55:32 GMT

This Database Table is a one-page table of hard-to-find numerical information Database Tables are proprietary data sources covering specific information for the diagnostic, medical device, biotechnology, healthcare and IT sectors Over 600 database tables are now available from Research and Markets A...

Technology Developments in Functional Proteomics (Technical Insights)

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:12 GMT

This research service titled Functional Proteomics provides an overview of enabling technologies in functional proteomics, along with a complete analysis of key market drivers, restraints, applications, and trends that are impacting the field In this study, Frost & Sullivans expert analysts...

Proteomics - Global Strategic Business Report

press@researchandmarkets.com — Tue, 15 Aug 2006 14:04:04 GMT

This report analyzes the worldwide markets for Proteomics in Millions of US$. The major Product segments analyzed are Expression Proteomics, Functional Proteomics, and Structural Proteomics.The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2003 through 2015. The report profiles 170 companies including many key and niche players worldwide such as Agilent Technologies, Inc., Applied Biosystems, Bio-Rad Laboratories, Inc., Dionex Corporation, GE Healthcare, Biacore Life Sciences, Invitrogen Corporation, PerkinElmer, Inc., Proteome Systems Ltd., Shimadzu Biotech, and Thermo Fisher Scientific. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

For information on site licence pricing please click on Enquire before buying

Sector Snapshot: Protein and Antibody Microarrays Markets

press@researchandmarkets.com — Fri, 04 Aug 2006 15:53:58 GMT

This “Sector Snapshot” is designed to provide a high-level overview of a particular market sector, including key players, sales data and emerging trends. This sector snapshot covers the worldwide market for microarrays and microarray market drivers, which include the life sciences and diagnostics sectors. This snapshot also addresses protein arrays, antibody arrays, antibody therapeutic agents, and future applications.

Microarray Markets

press@researchandmarkets.com — Thu, 20 Apr 2006 14:42:40 GMT

A microarray is an arrangement of miniaturized test sites or "spots" on a surface Each spot is usually no more than 250 micrometers in diameter and contains biological molecules--usually DNA or protein--which act as probes for a test sample applied to the array The surface may be a glass slide, a...

Protein Therapeutics Production: Large-scale Mammalian Cell Culture

press@researchandmarkets.com — Tue, 03 Jan 2006 17:13:02 GMT

"Protein Therapeutics Production: Large-scale Mammalian Cell Culture" provides an introduction and overview of current manufacturing practices associated with large scale mammalian cell culture. The focus is on the use of large scale mammalian cell culture systems.

The industry, which began in

Fluorescent Proteins: Technologies, Applications, and Opportunities for Drug Discovery

press@researchandmarkets.com — Fri, 24 Sep 2004 11:54:52 GMT

Fluorescent proteins are fast providing novel insights into compound-induced responses in drug discovery This is taking place from two key vantage points, namely, in real time and in living systems With non-invasive, non-destructive properties along with the benefit of being genetically-encoded,...

Global Market for DNA Sequencing Analysis, 2000-2008

press@researchandmarkets.com — Wed, 10 Mar 2004 01:40:04 GMT

Post Genome Project Era Proteomics R&D Competition

press@researchandmarkets.com — Mon, 15 Dec 2003 22:34:43 GMT

Proteomics is projected to grow from a $565 million market in 2001 to over $3.3 billion in 2006. This represents an average annual rate of growth of over 40%. The fastest growing segment of the proteomics market is expected to be the protein chip segment

Proteomics - Technologies, Markets and Companies

press@researchandmarkets.com — Wed, 22 Oct 2003 23:36:00 GMT

This report describes and evaluates the proteomic technologies that will play an important role in drug discovery, molecular diagnostics and practice of medicine in the post-genomic era - the first decade of the 21st century Most commonly used technologies are 2D gel electrophoresis for protein...